- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01946737
High Definition CT Coronary Angiography Accuracy Trial
Diagnostic Performance of 64 Slice High Definition Computed Tomographic Coronary Angiography in Patients With High Risk of Significant Coronary Artery Disease.
CT technology is evolving at a rapid pace, with introduction of multidetector row CT scanners (MDCT) and electrocardiographic (ECG) gating resulting in increasing numbers of heart scans CTCA (CT Coronary Angiography). CTCA provides a noninvasive alternative to conventional invasive coronary angiography (ICA), which is considered the gold standard in the investigation of coronary disease. There has been a gradual increase in the utilization of CTCA for primary assessment of low and intermediate risk patients. However concerns regarding radiation exposure and diagnostic accuracy, especially in the highrisk group, have prevented its widespread dissemination.
To achieve best possible temporal resolution (minimize cardiac motion artifacts) and spatial resolution (provide diagnostic accuracy) relatively high radiation exposure is required, as a result of its inverse relationship with image noise and resolution. However radiation (X-ray) is associated with increased risk of cancer in exposed patients and it is therefore essential to continually devise strategies to reduce radiation exposure whilst maintaining image quality.
A state-of-art CT scanner (Discovery CT750 HD, General Electric (GE) Healthcare), has been installed at Derriford hospital for further research on CTCA. It uses novel method of scanning, High Definition Computed Tomographic Coronary Angiography(HD-CTCA), analogous to high definition television) and image reconstruction (Adaptive Statistical Iterative Reconstruction ASIR)as opposed to conventional CT scanners using Filtered Back Projection (FBP)reconstruction. HD-CTCA enables acquisition of sharper images and ASIR offsets the resultant increase in radiation exposure. This is likely to result in images of higher diagnostic quality with an equivalent or slightly lower radiation exposure compared to present technology. Although initial results are encouraging, this needs further assessment before being applied to routine clinical practice. To assess this we have designed a study to perform HD-CTCA on 300 consecutive patients undergoing diagnostic ICA at Derriford hospital, directly comparing the accuracy of HD-CTCA to ICA (presently considered the gold standard).
Hypotheses:
There is no significant difference in the sensitivity and specificity of HD-CTCA for the detection of coronary artery stenosis of 50% or greater compared to conventional ICA.
Study Overview
Status
Conditions
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Devon
-
Plymouth, Devon, United Kingdom, PL6 8BX
- Plymouth Hospitals NHS Trust
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Patients > 40 years of age.
- Suspected or known coronary artery disease
- Admitted for diagnostic ICA
Exclusion Criteria:
- Consent cannot be obtained
- Age <40 years
- New York Heart Association (NYHA) Functional Classification - class III or IV heart failure
- Emergency imaging required (not enough time to consider the trial)
- Allergy to iodinated contrast or previous contrast induced nephropathy
- Intolerance to betablockers
- Uncontrolled rhythm disturbances (not suitable for CTCA)
- Serum Creatinine >200 micro mol/L within two weeks prior to procedure or chronic renal failure on dialysis
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
- Allocation: Non-Randomized
- Interventional Model: Crossover Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Invasive coronary angiography (ICA)
Routine diagnostic ICA
|
|
|
Experimental: HD-CTCA with ASIR
HD-CTCA with Adaptive statistical iterative reconstruction (ASIR)within 4 weeks of routine diagnostic ICA
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Diagnostic accuracy of HD-CTCA for the detection of at least moderate stenosis (>50%) as defined on invasive coronary angiography in the high-risk target population.
Time Frame: 4 weeks
|
We designed the New Generation Computed Tomographic Coronary Angiography (NG-CTCA) study to assess the diagnostic accuracy of high-definition CT with iterative reconstruction in an unselected population of patients suitable for CTCA with either a high pre-test probability of, or established coronary artery disease.
Our hypothesis is that NGCT has a comparable diagnostic performance to invasive coronary angiography (ICA), using this as the reference standard
|
4 weeks
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
The diagnostic accuracy of HD-CTCA for the detection of severe stenosis (70%) as defined by invasive coronary angiography.
Time Frame: 4 weeks
|
4 weeks
|
Other Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
The radiation dose delivered by HD-CTCA
Time Frame: 4 weeks
|
4 weeks
|
Collaborators and Investigators
Investigators
- Study Chair: Carl Roobottom, BSc, MBChB(hon), MRCP. FRCR, University Hospital Plymouth NHS Trust
- Principal Investigator: Srikanth Iyengar, MBBS, MS, FRCS, FRCR, University Hospital Plymouth NHS Trust
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 11/P/050
- 11/H0206/5 (Other Identifier: UK REC Reference Number)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Coronary Artery Disease
-
Infirmerie Protestante de LyonRecruitingCoronary Artery Bypass | Coronary Artery Disease(CAD) | Off Pump Coronary Artery Bypass Surgery | Hemodynamic Optimization | Hemodynamic Management | Off Pump Coronary Artery Bypass Graft | Coronary Artery Disease With Need for Bypass Surgery | NoradrenalineFrance
-
Shanghai Bluesail Boyuan Medical Technology Co....Not yet recruitingCoronary Artery Disease | Coronary Artery Calcification | Severe Coronary Artery DiseaseChina
-
I.R.C.C.S Ospedale Galeazzi-Sant'AmbrogioCompletedCoronary Artery Disease (CAD) | Atherosclerosis of Coronary ArteryItaly
-
Scitech Produtos Medicos SANot yet recruitingCoronary Artery Disease (CAD) | Multivessel Coronary Artery Disease | Complex Coronary Lesions | Calcific Coronary Arteriosclerosis | Small Vessel Ischemic Disease | Stenosis CoronaryBrazil
-
Istanbul Mehmet Akif Ersoy Educational and Training...Bakirkoy Dr. Sadi Konuk Research and Training Hospital; Ege University; Istanbul... and other collaboratorsActive, not recruitingCoronary Artery Disease (CAD) | Coronary Bifurcation Lesion | Left Main Coronary Artery StenosisTurkey (Türkiye)
-
University Medical Centre LjubljanaRecruitingCoronary Artery Disease With Myocardial InfarctionSlovenia
-
EBI Anti Sepsis BVCR2O B.V.Not yet recruitingCoronary Artery Disease (CAD) | Coronary Artery Bypass Graft Surgery(CABG)United States, Netherlands, Belgium, United Kingdom
-
Mahidol UniversityThe Princess Mantarop Kamalas Foundation, The Nurses' Association of Thailand and other collaboratorsActive, not recruitingCoronary Artery Disease (CAD) | Postoperative Recovery | Coronary Artery Bypass Graft (CABG)Thailand
-
Fundación EPICActive, not recruitingCoronary Artery Disease | Left Main Coronary Artery Disease | Left Main Coronary Artery Stenosis | Restenosis, CoronarySpain
-
Elixir Medical CorporationIstituto Clinico HumanitasActive, not recruitingCoronary Artery Disease | Chronic Total Occlusion of Coronary Artery | Multi Vessel Coronary Artery Disease | Bifurcation of Coronary Artery | Long Lesions Coronary Artery DiseaseItaly
Clinical Trials on Active Comparator: Invasive coronary angiography (ICA)
-
Charite University, Berlin, GermanyCompleted
-
Lauri MansikkaniemiCompletedCoronary Artery Disease | Chronic Total Occlusion of Coronary ArteryFinland
-
Abbott Medical DevicesCompletedCoronary Artery Disease | Coronary StenosisUnited States
-
Fujita Health UniversityRecruiting
-
Hemolens Diagnostics Sp. z o.o.KCRICompleted
-
Hemolens Diagnostics Sp. z o.o.GENELYTICA Sp. z o.o.CompletedCoronary Artery Disease | Stable Ischemic Heart DiseasePoland
-
HeartFlow, Inc.Case Western Reserve UniversityCompletedCoronary Artery DiseaseDenmark
-
Charite University, Berlin, GermanyCompletedCoronary Artery DiseaseAustria, Hungary, Germany, United Kingdom, Romania, Czechia, Denmark, Ireland, Italy, Latvia, Lithuania, Poland, Portugal, Serbia, Spain
-
St. Olavs HospitalNorwegian University of Science and Technology; Helse Nord-Trøndelag HF; Alesund... and other collaboratorsActive, not recruitingNon-ST Elevated Myocardial InfarctionNorway
-
Johns Hopkins UniversityCanon Medical Systems, USACompletedCoronary Artery DiseaseUnited States